News
FDA warns of risks of excessive dosing of obeticholic acid
Liver function should be monitored at baseline and during treatment for safe dosing.
News
Do not withhold opioid addiction drugs from patients taking benzodiazepines
The FDA says the benefits of combining MAT drugs with CNS depressants outweigh the risks.
News
Parents of very preterm and VLBW infants have resilient quality of life decades later
Children’s mental health problems, poor peer relationships predicted a poorer quality of life for their parents decades later.
News
Ten-year outcomes support skipping axillary lymph node dissection with positive sentinel nodes
Ten-year overall survival was 86.3% in the sentinel lymph node dissection group, compared with 83.6% in the axillary lymph node dissection group,...
News
Three percent of high school seniors report using synthetic cannabinoids
Risk of adverse effects, including death, is higher.
News
Tivozanib gets EU approval for advanced RCC
This is the first regulatory approval for tivozanib, which was rejected by the FDA in 2013 for the treatment of RCC.
News
Exelixis seeks expanded indication for cabozantinib in RCC
The supplemental New Drug Application is based on results from the CABOSUN trial.
News
Cognitive impairment in MS may affect fitness to drive motor vehicles
But impairment does not necessarily predict a road test failure.
News
Researchers develop 30-min antibiotic susceptibility test for UTI
New research suggests it is possible to develop a point-of-care test for patients with urinary tract infections.
News
South African child has suppressed HIV without ART since infancy
The first case of sustained HIV control in a child enrolled in a randomized trial of antiretroviral therapy interruption after treatment early in...
News
Abilify Maintena OK’d by FDA for adults with bipolar I disorder
Approval of the long-acting injectable form of aripiprazole is based on a 52-week withdrawal trial in adults.
News
First interchangeability study for an adalimumab biosimilar has begun
The trial recently enrolled its first patient.
News
New monotherapy approved for partial-onset seizures
Perampanel (Fycompa) has been approved for monotherapy treatment of partial-onset seizures in patients aged 12 years or older.
News
Self-injectable belimumab receives FDA approval for systemic lupus erythematosus
The new formulation is the first self-injectable subcutaneous treatment available for patients with SLE.
News
FDA okays ClearLLab test for hematologic cancer detection
New way to test for certain cancers shows promise.